To examine whether BRAF mutant alleles are selected for in melanoma progression, we enumerated BRAF mutant alleles by subcloning in three cases where the pairs of primary tumour and recurrent primary tumour or metastases were available for analyses (Table 3). The gene discussed is BRAF; the disease is melanoma.